Hot Products
| Catalog No. | Information |
| CFN90332 | Dihydromethysticin Dihydromethysticin non-competitively inhibits the specific binding of [3H]-batrachotoxinin-A 20-alpha-benzoate to receptor site 2 of voltage-gated Na+ channels.The induction of CYP3A23 by dihydromethysticin and desmethoxyyangonin involves transcription activation, probably through a pregnane X receptor (PXR).-independent or PXR-involved indirect mechanism. |
| CFN99854 | Dihydromorin trans-Dihydromorin is an effective hypopigmenting agent in normal skin cells, hypopigmenting agents effective in melanoma system may not be effective on normal melanocytes, indicating that a non-tumor melanocyte system is more suitable for the screening of hypopigmenting agents. Dihydromorin shows strong mushroom inhibitory activity with IC50 values lower than 50 microM, more potent than (IC50 = 71.6 microM), it may be as an antibrowning agent in food systems. |
| CFN99253 | Dihydroniloticin Dihydroniloticin shows cytotoxic activity against a HT-1080 human fibrosarcoma cell line( IC50 = 8.2 microM). |
| CFN92591 | Dihydrooroxylin A Dihydrooroxylin A has significant antifeeding activity. |
| CFN93083 | Dihydropalmatine Reference standards. |
| CFN98657 | Dihydrophaseic acid Dihydrophaseic acid 3’-O-b-D-glucopyranoside (D3G) can increase the proliferation and differentiation of osteoblast cells and enhance bone formation, suggests that D3G may be a good candidate for the treatment of osteoporosis. |
| CFN95393 | Dihydrophaseic acid 4'-O-beta-D-glucopyranoside |
| CFN99829 | Dihydropinosylvin methyl ether Reference standards. |
| CFN98987 | Dihydroresveratrol Dihydroresveratrol has antiproliferative activity against human prostate cancer PC3 cell line in vitro, it can ameliorate acute pancreatitis-associated lung injury via an inhibitory modulation of pro-inflammatory response, which is associated with a suppression of the NF-κB signaling pathway. |
| CFN99021 | Dihydroresveratrol 3-O-glucoside Reference standards. |
